MEGAN PATTEE: Open Payments
NPI 1730721770 · CASTLE ROCK, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,948 in 109 payments from 14 companies in 2025. Trend: 2023 $783 · 2024 $1,910 · 2025 $1,948
Food & beverage: $1,849Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $461 |
| Janssen Biotech, Inc. | 9 | $280 |
| UCB, Inc. | 15 | $252 |
| LEO Pharma Inc. | 15 | $225 |
| Novartis Pharmaceuticals Corporation | 8 | $183 |
| Galderma Laboratories, L.P. | 13 | $135 |
| Organon LLC | 15 | $127 |
| GENZYME CORPORATION | 3 | $70 |
| Regeneron Healthcare Solutions, Inc. | 2 | $63 |
| Incyte Corporation | 3 | $60 |
Products named: TREMFYA, Bimzelx, BOTOX, SKYRIZI, COSENTYX, ADBRY, DUPIXENT, NEMLUVIO.
Industry payments across CO — which companies pay providers there.
